SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is generating significant community conversation as investors debate the impact of the Clarity Act and broader regulatory shifts, with active engagement surrounding ecosystem projects like UPDOG. While market participants remain divided over long-term price potential compared to traditional assets, the community continues to focus on staking strategies and the potential for increased institutional adoption.

Shping takes the entire retail industry to the next level by totally disrupting how brands discover and interact with their end consumers. Shping is a robust ecosystem that connects brands to the main grocery buyer as they shop, bypassing Search Engines and Social Media giants and enabling brands to direct their marketing spend directly to the end consumer. For the first time, brands can gain control over their communication channel with the shoppers directly and are now powered to influence buying decisions of the global army of shoppers in a trillion-dollar industry.  The Shping platform is used by many global and local brands where Shping has outperformed in cost in terms of interactions and conversions compared to the top 3 three social media platforms.

SHPING

SHPING is trending as investors aggressively speculate on a potential price surge, driven by rumors of imminent AI-related developments and new exchange listings. Community members are actively debating whether this is a genuine breakout opportunity or another typical pump-and-dump cycle, with many emphasizing its low market cap and long-term utility as reasons to hold.

Bitwise Hyperliquid ETF - Bitwise Hyperliquid ETF

Bitwise Hyperliquid ETF

BHYP is trending as investors react to the Bitwise Hyperliquid ETF debut, with community members highlighting its role in providing direct institutional access to the Hyperliquid ecosystem. Discussions are heavily focused on the potential for unrelenting institutional buying pressure and the ongoing debate surrounding its long-term growth potential compared to other major crypto assets.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee ($LKNCY) is rallying as investors react to strong double-digit revenue growth and the company's first-ever $300 million share buyback program. The community is buzzing over this signal of institutional confidence, with many traders speculating that these proactive capital measures are a deliberate step toward an eventual relisting on a major U.S. exchange.

Morgan Stanley operates as a global financial services company. The firm provides investment banking products and services to its clients and customers including corporations, governments, financial institutions, and individuals. It operates through the following segments: Institutional Securities, Wealth Management, and Investment Management. The Institutional Services segment provides financial advisory, capital-raising services, and related financing services on behalf of institutional investors. The Wealth Management segment offers brokerage and investment advisory services covering various types of investments, including equities, options, futures, foreign currencies, precious metals, fixed-income securities, mutual funds, structured products, alternative investments, unit investment trusts, managed futures, separately managed accounts, and mutual fund asset allocation programs. The Investment Management segment provides equity, fixed income, alternative investments, real estate, and merchant banking strategies. The company was founded by Harold Stanley and Henry S. Morgan in 1924 and is headquartered in New York, NY.

Morgan Stanley

Morgan Stanley is trending as investors digest the firm's strategic push into crypto ETFs and its role as a key player in navigating high-profile IPO activity. The community is actively debating the bank's long-term growth potential and its leadership in deal-making amid a volatile macro environment.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson is seeing significant investor attention driven by strong earnings momentum and growth in its Innovative Medicine and MedTech segments, even as it navigates ongoing talc-related legal overhangs. The community is actively debating the stock's defensive rotation status versus the potential impact of long-term litigation exposure.

Jupiter is a cryptocurrency exchange platform on the Solana blockchain, offering features such as token swapping, limit orders, dollar-cost averaging, and a bridge for asset transfers to Solana. It provides users with tools to find the best trading prices and includes a beta version for perpetual futures trading. Jupiter finds the best price route for your swap by aggregating all the major liquidity sources on Solana.

Jupiter

Willis Towers Watson Plc engages in the provision of advisory, broking, and solutions services. It operates through the following segments: Health, Wealth, and Career (HCW), Risk and Broking (R&B), and Corporate and Other. The HCW segment provides an array of advice, broking, solutions, and technology for employee benefit plans, institutional investors, compensation and career programs, and the employee experience overall. The R&B segment focuses on a broad range of risk advice, insurance brokerage, and consulting services to clients globally, ranging from small businesses to multinational corporations. The company was founded in 1828 and is headquartered in London, the United Kingdom.

Willis Towers Watson Public Limited Co

WTW is currently trending as investors monitor its organic growth recovery and margin expansion efforts following mixed reactions to recent earnings. Market participants are actively discussing the impact of AI fee compression and potential pricing tailwinds from geopolitical risks while keeping a close eye on the stock's performance relative to key support levels.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.

Abbvie Inc

AbbVie is trending as investors weigh strong financial performance in its immunology franchise against ongoing revenue headwinds from the decline of its legacy blockbuster, Humira. Community discussion is heavily focused on the company's aggressive M&A strategy to secure new growth drivers and its potential future role in the competitive weight-loss medication market.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

BAYRY's Kerendia Label Expansion Application Gets Priority Review 

Bayer wins FDA Priority Review for Kerendia label expansion in CKD tied to type I diabetes after strong phase III data.

BAYRY or RHHBY: Which Is the Better Value Stock Right Now?

BAYRY vs. RHHBY: Which Stock Is the Better Value Option?

Regeneron & Parabilis Sign Oncology Collaboration Worth Up to $2.2B

REGN teams up with Parabilis in a potential $2.2B deal to develop Antibody-Helicon Conjugates targeting hard-to-treat cancers.

FDA Grants Priority Tag to Bayer's Oncology Drug for First-Line NSCLC

BAYRY wins FDA priority review for sevabertinib in first-line HER2-mutant NSCLC, building momentum for the oral TKI.

Bayer Gets FDA Priority Review for Asundexian NDA in Stroke Prevention

BAYRY gains FDA Priority Review for asundexian NDA after phase III data showed a 26% cut in ischemic stroke risk without more major bleeding.

Bayer Q1 Earnings Beat Estimates, Crop Science Unit Boosts Sales

BAYRY beats Q1 earnings estimates as Crop Science sales rise, while Nubeqa and Kerendia gains help offset declines in Xarelto and Eylea.

CPI Comes in Line With Expectations

CPI Inflation Rate Heats Up to +3.8%

We can see clearly how disruptions in the Strait of Hormuz have affected energy prices: +3.8% overall, +5.4% for gasoline.

CYTK Q1 Earnings Match Estimates, Revenues Beat on Myqorzo Launch

Cytokinetics posts Q1 loss as Myqorzo launch lifts revenues to $19.4M, signaling commercial shift amid rising SG&A tied to rollout and expansion.

Regeneron Q1 Earnings Top, Sales Up on Dupixent & Eylea HD Strength

REGN tops Q1 estimates with strong Dupixent and Eylea HD growth, but the stock slips as Eylea sales plunge and competition intensifies.

Bayer AG engages in the business of life science fields of healthcare and nutrition. It operates through the following segments: Crop Science, Pharmaceuticals, and Consumer Health. The Crop Science segment includes developing, producing, and marketing products in seeds and plant traits, crop protection, digital solutions, and customer services to promote sustainable agriculture. The Pharmaceuticals segment is involved in prescription products especially for cardiology and women’s health; specialty therapeutics in the areas of oncology, hematology, ophthalmology, and cell and gene therapy; diagnostic imaging equipment; and necessary contrast agents. The Consumer Health segment focuses on non-prescription products in the dermatology, nutritional supplements, digestive health, allergy, cough and cold, and pain and cardiovascular risk prevention categories. The company was founded by Friedrich Bayer and Johann Friedrich Westkott on August 1, 1863 and is headquartered in Leverkusen, Germany.

Current Price	$11.11
Prev Close	$11.28
Open	$11.23
Dividend Yield	0.21%
50-Day Moving Average	$11.27
Beta	0.47
Avg. Volume	1.48M
PE Ratio	-17.52

52-Week High	$14.85
52-Week Low	$6.97
Market Capitalization	$43.66B
EPS (Annual)	-$1.04
Price to Book	1.31
Revenue Per Employee	$583,970.35

BAYRY
Bayer AG (ADR)

Feed

News

Sentiment

Earnings

Fundamentals

Info

Compact View

Latest BAYRY News

BAYRYBayer AG (ADR)